Term
|
Definition
Levothyroxine (Synthroid®)
Liothyronine (Cytomel®)
Liotrix (Thyrolar®)
Thyroglobulin (Proloid®)
Thyroid, dissected (Armour® Thyroid)
MOA: Provides the body with thyroid hormone (T4 or T3) to replace the lack of thyroid hormone in hypothyroidism
SE: Palpitations, increased appetite, tachycardia, nervousness, tremor, weight loss, sweating, diarrhea, insomnia, alopecia, heat intolerance, anxiety, nausea, headache, fever |
|
|
Term
|
Definition
Levoxyl®, Synthroid®, Levothroid®
Preferred drug for hypothyroidism
Dose: 100-150 mcg po daily
Hypothyroid Treatment |
|
|
Term
|
Definition
Cytomel®, Triostat®
Hypothyroid Treatment |
|
|
Term
|
Definition
Thyrolar®
Hypothyroid Treatment |
|
|
Term
|
Definition
Proloid®
Hypothyroid Treatment |
|
|
Term
|
Definition
Armour® Thyroid
Hypothyroid Treatment |
|
|
Term
|
Definition
Iodide
Propyithiouracil (PTU)
Methimazole (Tapazole®)
Radioactive Iodine (I131)
Propranolol (Inderal®)
Diltiazem (Cardizem®)
Verapamil (Calan®)
Prednisone (Deltasone®)
|
|
|
Term
|
Definition
No Brand Name
MOA: Inhibits thyroid hormone release, block iodotyrosine and iodothyronine synthesis, decrease vascularity of the thyroid gland; can rapidly decrease serum T4 concentration
Hyperthyroid Adjunct Treatment |
|
|
Term
|
Definition
PTU
MOA: Inhibits hormone synthesis but does not affect existing hormone levels, also inhibits the conversion of T3 or T4. It is the drug of choice for thyroid storm.
Dose: 100-150 mg q8 hours, then reduce to 50 mg 2-3 times daily after euthyroid state is reached
SE: Abnormal sense of taste, itching, rash, fever, arthralgias
Thioamides (Hyperthyroid Treatment) |
|
|
Term
|
Definition
Tapazole®
MOA: Inhibits hormone synthesis, but does not affect existing stores of thyroid hormone; preferred over PTU because it is dosed once daily to enhance compliance
Dose: 5-15 mg BID up to 30 mg BID; MD: 5-10 mg daily
SE: Abnormal sense of taste, itching, rash, fever, arthralgia
Thioamide (Hyperthyroid Treatment) |
|
|
Term
|
Definition
I131
SE: Hypothyroidism, worsening of ophthalmopathy, fear of radiation induced leukemia, genetic damage, malignancy, radiation sickness
Hyperthyroid Treatment |
|
|
Term
|
Definition
Inderal®
MOA: Blocks effects of thyroid hormone peripherally, no effect on underlying disease, blocks T4 to T3 conversion
Dose: 10-40 mg q6 hour to prn to decrease HR <100 bpm
SE: Bradycardia, CHF, bronchospasms, blocks symptoms of hypoglycemia
Beta Blocker (Hyperthyroid Treatment) |
|
|
Term
|
Definition
Cardizem®
MOA: Blocks effect of thyroid hormone peripherally, no effect on underlying disease
Dose: 120 mg 3 to 4 times daily
SE: Bradycardia, peripheral edema, CHF, headache, flushing, hypotension, dizziness
Calcium Channel Blocker (Hyperthyroid Treatment) |
|
|
Term
|
Definition
Calan®
MOA: Blocks effects of thyroid hormone peripherally, no effect on underlying disease
Dose: 80-120 mg 3 to 4 times daily
SE: Bradycardia, peripheral edema, CHF, headache, flushing, hypotension, dizziness
Calcium Channel Blocker (Hyperthyroid Treatment) |
|
|
Term
|
Definition
Deltasone®
MOA: Decreases thyroid receptor antibodies, supresses inflammatory process, blocks conversion of T4 to T3
Corticosteroid (Hyperthyroid Treatment) |
|
|